Oppenheimer analyst Kevin DeGreeter raised the price target on Exact Sciences (NASDAQ: EXAS) to $161.00 (from $153.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE